The local institution owns the application
Regulatory approval is the responsibility of the local partner and is conducted through the national regulatory authority of the host country.
VectorGene supports the documentation, technical files, evidence packages and submission preparation. The formal application and ownership of the regulatory dossier remain with the local institution.
That division of responsibility should be clear when scope, responsibilities, timelines and the IP framework are agreed. Technology transfer does not transfer the national regulator’s authority to the technology provider.
Eight areas of regulatory and quality support
The programme’s feasibility assessment identifies which support areas apply. The final documentation scope and responsibilities depend on the selected platform, local infrastructure and host country requirements.
- Regulatory pathway planning
- Ethics & clinical trial documentation
- GMP facility & cleanroom planning
- SOP & batch record development
- QC & release testing framework
- Patient eligibility & workflow
- Adverse event reporting framework
- Long-term follow-up planning
A status label is a starting point
Every platform and service is shown with its regulatory context. Approvals in some markets do not imply approval in the host country. Investigational and research-use platforms are not presented as standard care.
For a specific programme, confirm the permitted indication or intended use, the applicable national pathway, ethics review and the evidence the authority requires. Read the complete regulatory note rather than relying on the status badge alone.
Ownership continues into operation
The supplied transfer scope includes documentation, release testing protocols, an adverse event framework and long-term follow-up planning. Those deliverables belong within a locally operated quality and governance system.
An operating facility needs people who understand its processes and records. Training, competency assessment and documented responsibilities support the goal of capability that outlives the engagement.
Prepare the first conversation
Programme-specific regulatory advice and approvals remain necessary. This draft is an institutional explanation, not jurisdiction-specific legal or clinical advice.
- Identify the institution’s dossier owner and clinical governance lead.
- Confirm the authority and ethics-review route for the intended use.
- Document the current facility, workforce and quality-system baseline.
- List the documentation and evidence gaps to resolve in feasibility.
